Our Faculty
Sydney M. LeFay, D.O.
Salem Health
Biography
Dr. Sydney LeFay (she/they) graduated from the consultation-liaison fellowship at Oregon Health & Science University in 2019, and since then has worked in inpatient medical, emergency room, and acute care psychiatry settings in the United States and New Zealand. In addition to her clinical work, Dr. LeFay is an avid clinical educator and has made academic contributions on a range of topics including transgender health, psychosomatic medicine, and trauma-related disorders. She continues to utilize her group dynamic skills in her consultative roles and remains connected to her roots in group psychotherapy training through the American Group Psychotherapy Association.
Publications of Sydney M. LeFay, D.O.
Quick Take Vol. 61
0.50 CMEs
In this Quick Take volume, we revisit the utilization of droperidol as a strategy for handling agitation and ponder on the discontinuation of benzodiazepines and Z-drugs among hospitalized elderly patients. Are there alternate approaches for discontinuation that could be undertaken during hospitalization?
We also question the efficacy of gabapentin in treating post-COVID-19 anosmia, its possible association with neurodegenerative diseases, and whether high-dose olanzapine is a feasible treatment for resistant schizophrenia. Finally, do antidepressants influence the effectiveness of psychotherapy?
Faculty: Scott R. Beach, M.D., Paul Zarkowski, M.D., Oliver Freudenreich, M.D., Sydney M. LeFay, D.O.
34.13 minutes in 5 audio sections
Quick Take Vol. 58
0.50 CMEs
In this Quick Take volume, our expert faculty examine a range of critical topics, beginning with an exploration of plasma concentrations of SSRI/SNRI post-bariatric surgery and their impact on depressive symptoms. They also investigate the potential of psychedelics as transformative therapeutics in mental health care as well as the efficacy and safety of antidepressants in patients suffering from both depression and other medical diseases. Additionally, the use of daridorexant among patients with chronic insomnia and an international research agenda focusing on clozapine-resistant schizophrenia are discussed.
Faculty: Scott R. Beach, M.D., Carlos H. Schenck, M.D., Oliver Freudenreich, M.D., Sydney M. LeFay, D.O.
35.46 minutes in 5 audio sections
Quick Take Vol. 56
0.75 CMEs
In this Quick Take volume, our expert faculty examine research on the possible effects of prenatal exposure to antidepressants across various trimesters of gestation as well as the safety and efficacy of lithium augmentation for the management of treatment-resistant depression. Our faculty also discuss studies regarding antipsychotics and liver safety as well as inappropriate medication use among older adults.
Faculty: Vivien K. Burt, M.D., Ph.D., Scott R. Beach, M.D., Paul Zarkowski, M.D., Lauren Osborne, M.D., Sydney M. LeFay, D.O.
38.05 minutes in 5 audio sections